Secondary CD5+ diffuse large B-cell lymphoma not associated with transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (Richter syndrome).

Abstract

Few cases of secondary CD5+ diffuse large B-cell lymphoma (DLBCL) that are not Richter syndrome have been reported previously. We report 9 cases of non-Richter syndrome secondary CD5+ DLBCL. Among 529 cases of DLBCL, 38 (7.2%) were CD5+ DLBCL, including 9 of secondary CD5+ DLBCL. Five cases gained CD5 expression during the clinical course of DLBCL (group 1). Three cases showed transformation from CD5- low-grade B-cell lymphoma to CD5+ DLBCL (group 2). The remaining case showed coexistence of CD5+ DLBCL and CD5+ follicular lymphoma. The clonal relationships of CD5- and CD5+ tumors were confirmed in all 4 available cases. Cases of secondary CD5+ DLBCL that were not Richter syndrome were classifiable into 3 groups. Groups 1 and 2 showed the gain of CD5 during the clinical course or transformation of the tumors, suggesting that CD5 expression is closely associated with the progression of B-cell lymphoma.

DOI: 10.1309/AJCP58FETFGLCKKW

Statistics

0100200200920102011201220132014201520162017
Citations per Year

145 Citations

Semantic Scholar estimates that this publication has 145 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Maeshima2009SecondaryCD, title={Secondary CD5+ diffuse large B-cell lymphoma not associated with transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (Richter syndrome).}, author={Akiko Miyagi Maeshima and Hirokazu Taniguchi and Junko Nomoto and Dai Maruyama and Sung-Won Kim and Takashi Watanabe and Yukio Kobayashi and Kensei Tobinai and Yoshihiro Matsuno}, journal={American journal of clinical pathology}, year={2009}, volume={131 3}, pages={339-46} }